tiprankstipranks
Trending News
More News >

Medicenna Shareholders Show Strong Support at Annual Meeting

Story Highlights
Medicenna Shareholders Show Strong Support at Annual Meeting

Medicenna Therapeutics Corp (TSE:MDNA) has released an update.

Confident Investing Starts Here:

Medicenna Therapeutics Corp. successfully held its annual meeting, resulting in the re-election of all board nominees with high approval rates. Shareholders also approved the appointment of MNP LLP as the company’s auditor. This signifies continued investor confidence in Medicenna, a clinical-stage immunotherapy company developing innovative treatments for cancer and other diseases.

For further insights into TSE:MDNA stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App